Form 4 Tracker
Editas Medicine, Inc.
EDIT

21 insider filings · Latest: Sep 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 3, 2025Jun 2 9:32 PMO'Neill Gilmore Neil
Proposed Sale
20,000$1.87$37.4K—

View →

Mar 3, 2025Feb 28 9:40 PMO'Neill Gilmore Neil
Proposed Sale
35,000$1.86$65.1K—

View →

Mar 3, 2025Feb 28 9:39 PMLucera Erick
Proposed Sale
8,000$1.86$14.9K—

View →

Mar 3, 2025Feb 28 9:35 PMBurkly Linda
Proposed Sale
6,000$1.86$11.2K—

View →

Sep 3, 2024Aug 29 8:19 PMO'Neill Gilmore Neil
Proposed Sale
3,000$3.92$11.8K—

View →

Sep 3, 2024Aug 29 8:17 PMMei Baisong
Proposed Sale
1,000$3.92$3.9K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 8, 2026Sep 9 8:58 PMDaniel Scott OryEVP, Chief Medical Officer
Grant/Award
950,000$3.03950,000(D)

View →

Aug 6, 2026Aug 7 9:16 PMPatrick Thomas Ellinor IIDirector
Grant/Award
103,400$2.90103,400(D)

View →

Jun 17, 2026Jun 22 8:31 PMBernadette ConnaughtonDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:30 PMJessica HopfieldDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:30 PMAndrew HirschDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:29 PMDavid ScaddenDirector
Grant/Award
51,700$2.5551,700(D)

View →

Jun 17, 2026Jun 22 8:28 PMElliott M. LevyDirector
Grant/Award
51,700$2.5551,700(D)

View →

Mar 12, 2026Mar 16 8:37 PMGilmore Neil O'NeillDirector, CEO
Grant/Award
1,015,200$2.541,015,200(D)

View →

Mar 12, 2026Mar 16 8:35 PMAmy ParisonSVP, Chief Financial Officer
Grant/Award
292,856$2.54292,856(D)

View →

Mar 12, 2026Mar 16 8:34 PMLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER
Grant/Award
292,856$2.54292,856(D)

View →